Acrospire Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-648
Closed -$10K 2745
2017
Q1
$10K Sell
648
-19,881
-97% -$307K 0.01% 1875
2016
Q4
$332K Buy
20,529
+5,800
+39% +$93.8K 0.14% 110
2016
Q3
$267K Buy
14,729
+3,800
+35% +$68.9K 0.18% 38
2016
Q2
$180K Buy
10,929
+5,300
+94% +$87.3K 0.13% 127
2016
Q1
$93K Buy
+5,629
New +$93K 0.06% 382